logo
School of Biomedical Sciences
   
   
  

Lipid signalling in Health and Disease

The Importance of Research in Lipid Signalling in Health and Disease

Lipids are crucial mediators of a host of molecular and cellular processes. Our research group investigates the contribution of bioactive lipids in a variety of physiological and pathophysiological settings. Endocannabinoids are small, ubiquitously expressed signalling lipids, and we have made significant contributions to the understanding of their function and metabolism, including their quantification in biological samples by liquid chromatography mass spectrometry. 

 

Our Research Interests in Lipid Signalling in Health and Disease

Our research encompasses a broad spectrum of activities, from classical receptor pharmacology through to the control of gene expression by direct interactions with transcription factors. The functional effects of bioactive lipids, such as the endocannabinoid anandamide, on neuronal activity are investigated with calcium imaging and electrophysiological approaches. Our research has relevance to a wide range of diseases including pain, Alzheimer’s, cancer, diabetes, liver disease and cardiovascular disease.

For more information, please email Professor Victoria Chapman

See research degree opportunities related to this group .

Arthritis Research UK Pain Centre

The work of the Arthritis Research UK Pain Centre has been spotlighted in a report recently published by Universities UK and Research Councils UK called Big Ideas for the Future.

 

Group Publications

Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices

Description
J Neurochem; Sarmad, S., Alexander, S.P., Barrett, D.A., Marsden, C.A., and Kendall, D.A.

A FAAH-fetched approach to treat osteoarthritis pain

Description
Pain; Lichtman, A.H. and Chapman, V.
 
 

School of Biomedical Sciences

University of Nottingham
Medical School
Queen's Medical Centre
Nottingham, NG7 2UH

telephone: +44 (0) 115 823 0141
email: enquiries